Accès à distance ? S'identifier sur le proxy UCLouvain
An Exploratory Study of Sunitinib (SU) Plus Docetaxel (D) and Trastuzumab (T) for First-Line Therapy of HER2+Advanced Breast Cancer (ABC).
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Présentation orale avec comité de sélection |
|---|---|
| Access type | Accès restreint |
| Publication date | 2009 |
| Language | Anglais |
| Conference | "32nd Annual San Antonio Breast Cancer Symposium", (United-States) San Antonio, Texas (du 09/12/2009 au 13/12/2009) |
| Journal information | "Cancer Research" - Vol. 69, no. 24, p. 852S-853S (2009) |
| Peer reviewed | yes |
| issn | 0008-5472 |
| e-issn | 1538-7445 |
| Publisher | American Association for Cancer Research ((United States) Chicago) |
| Publication status | Publié |
| Affiliations |
UCL
- MD/MINT - Département de médecine interne UCL - (SLuc) Unité d'oncologie médicale |
| Links |
| Bibliographic reference | Dirix, L. ; Machiels, Jean-Pascal ; Canon, Jean-Luc ; Amadori, D. ; Villa, E. ; et. al. An Exploratory Study of Sunitinib (SU) Plus Docetaxel (D) and Trastuzumab (T) for First-Line Therapy of HER2+Advanced Breast Cancer (ABC)..32nd Annual San Antonio Breast Cancer Symposium ((United-States) San Antonio, Texas, du 09/12/2009 au 13/12/2009). In: Cancer Research, Vol. 69, no. 24, p. 852S-853S (2009) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/58648 |